[1]
M. Maida, F. Macaluso, F. Valenza, and R. Virdone, “Complete and Sustained Off-Therapy Response to Sorafenib in Advanced Hepatocellular Carcinoma”, JGLD, vol. 25, no. 2, pp. 253-255, Jun. 2016.